• Outstanding Seal
  • Antimicrobial properties
  • Promotes per-apical healing
  • Easy obturations and follow-up

BioRoot™ RCS. Succeed.

For more information on this exciting new product go to 


Article: Volume 42 Number 9 Page 840 - November 2015

Prev    Article P840    Next  Read article

  Dent Update 2015; 42: 840-854

Oral surgery:  A New Generation of Antiplatelet and Anticoagulant Medication and the Implications for the Dental Surgeon

CPD:  CPD  0:24   (closed)      Self assess

Feedback:  0 comments, 0 ratings


Abstract: The management of dental patients taking either antiplatelet medication, anticoagulant medication or both has been well established in the previous literature. Recently, new generations of drugs have emerged which are becoming increasingly common, including direct thrombin inhibitors, factor X inhibitors and a new class of oral thienopyridines. The implications of these drugs for the dental surgeon are not yet fully known. Awareness remains low and there is very little information available within the literature on safe use during surgery. This review paper aims to provide some guidance for dental practitioners performing invasive procedures.

Clinical relevance: A new generation of anticoagulant and antiplatelet drugs have serious implications for patients undergoing surgery and their use is increasing.

Author notes: Steven Johnston, BDS, MSc, MFDS RCS(Ed), Dental Officer, NHS Orkney.

Objective: To increase awareness of both new generation antiplatelet and oral anticoagulant medication and the understanding of potential implications when performing invasive dental procedures on patients taking these medications.